Viewing Study NCT01692834


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2026-02-04 @ 3:15 PM
Study NCT ID: NCT01692834
Status: COMPLETED
Last Update Posted: 2014-08-01
First Post: 2012-09-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers
Sponsor: NeuroVive Pharmaceutical AB
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 99752
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators